COMPANY

Tempo Therapeutics Inc

HQ: San Diego, CA source · tempothera.com ↗ · West Coast

Keywords: tissue engineering

Location: San Diego, CA · source · Oct 13, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $14M in debt securities (Form D filed Sep 11, 2026). SEC Form D 0001813688-26-000003 (Sep 11, 2026)
Evidence (1 event)
- Sep 11, 2026 · SEC Form D 0001813688-26-000003
  Name of Issuer: Tempo Therapeutics, Inc.; CIK: 1813688; Address: San Diego, CA; Submission type: D; Filing date: 2026-09-11; Industry Group: Biotechnology; Date of First Sale: 2026-08-27; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 14500000; Total Amount Sold: 14000000; Federal exemptions: 06b
NIH award NIH awarded $1.42M (SBIR Phase II 1R44CA314892-01, new, notice Sep 17, 2026). NIH RePORTER 1R44CA314892-01 (Sep 17, 2026)
Evidence (1 event)
- Sep 17, 2026 · NIH RePORTER 1R44CA314892-01
  Organization: TEMPO THERAPEUTICS, INC.; City/State: San Diego, CA; Project number: 1R44CA314892-01; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-17; FY total cost (award amount): 1423186; Administering IC: National Cancer Institute; Project title: MOSAIC II: A Randomized Clinical Study of the MAP Wound Matrix to Reduce Time to Graft-Readiness after Non-Melanoma Skin Cancer Resection; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Sep 23, 2026 Grant Government grant: $2.25M (total, as published), announced Sep 23, 2026. Source: company's own press page. source ↗
Sep 17, 2026 Grant Government grant — SBIR: $1.42M (annual award, as published), announced Sep 17, 2026. Agency: NIH/NCI. Source: government award database. source ↗

Last 2 years.

Sep 23, 2026 Government grant: $2.25M (total, as published), announced Sep 23, 2026. Source: company's own press page. source ↗
Sep 17, 2026 Government grant — SBIR: $1.42M (annual award, as published), announced Sep 17, 2026. Agency: NIH/NCI. Source: government award database. source ↗

Annual award amounts. Total $4.4M.

Sep 1, 2022 NIH award 5R44DK130778-02 FY2022: $1,181,406 awarded for that fiscal year; activity R44 (SBIR); PI DESHAYES, STEPHANIE; recipient as written: TEMPO THERAPEUTICS, INC., San Diego, CA. A first in human clinical study o source ↗
Sep 15, 2021 NIH award 1R44DK130778-01 FY2021: $1,368,090 awarded for that fiscal year; activity R44 (SBIR); PI DESHAYES, STEPHANIE; recipient as written: TEMPO THERAPEUTICS, INC., San Diego, CA. A first in human clinical study o source ↗
Aug 17, 2020 NIH award 5R44DK124085-02 FY2020: $836,914 awarded for that fiscal year; activity R44 (SBIR); PI DESHAYES, STEPHANIE; recipient as written: TEMPO THERAPEUTICS, INC., San Diego, CA. MAP: a Flowable, Precision-Engineer source ↗
May 6, 2020 NIH award 3R44DK124085-01S1 FY2020: $24,685 awarded for that fiscal year; activity R44 (SBIR); PI DESHAYES, STEPHANIE; recipient as written: TEMPO THERAPEUTICS, INC., San Diego, CA. Diversity supplement for Oliver Vi source ↗
Sep 10, 2019 NIH award 1R44DK124085-01 FY2019: $737,053 awarded for that fiscal year; activity R44 (SBIR); PI DESHAYES, STEPHANIE; recipient as written: TEMPO THERAPEUTICS, INC., San Diego, CA. MAP: a Flowable, Precision-Engineer source ↗
Sep 16, 2016 NIH award 1R43DK109843-01 FY2016: $224,999 awarded for that fiscal year; activity R43 (SBIR); PI WEAVER, WESTBROOK M; recipient as written: TEMPO THERAPEUTICS, INC., San Diego, CA. A flowable microporous biomaterial source ↗